Aleksey N. Krylov, CFA, Finance Expert in New York, NY, United States
Aleksey N. Krylov, CFA

Finance Expert in New York, NY, United States

Member since November 15, 2016
Aleksey served in CFO roles of public and VC-backed private companies. As investor, he contributed to 25+ private equity deals that have deployed $500 million. He has advised 50+ clients on raising $1.6 billion in equity in the healthcare, consumer, media, software, energy, and industrial sectors. He enjoys working with officers of early stage and mature small-cap firms. He freelances because it exposes him to a wide range of companies.
Aleksey is now available for hire

Career Highlights


Case studies

Industry Expertise

  • Accounting Services
  • Automotive Service & Collision Repair
  • Energy, Utilities & Waste
  • Electricity, Oil & Gas
  • Finance
  • Banking
  • Venture Capital & Private Equity
  • Healthcare Services

Other Expertise


  • Business and Financial Consultant

    2009 - PRESENT
    Ftera Advisors
    • Supported Circle Peak Capital, a US-based family office which invested in control-stake positions in eight privately held consumer, health, and wellness companies with a combined $600 million in sales, in preparing and submitting a leveraged buyout bid for an Italian luxury cashmere products manufacturer. Led due diligence for the target. Built the LBO model. Coordinated lender diligence.
    • Supported Circle Peak Capital in the structuring of the equity investment into a startup digital media platform focused on women’s intimate apparel. Proposed terms and coordinated with lawyers on the drafting of closing documents.
    • Supported Circle Peak Capital in a $10 million recapitalization of a baked products manufacturer. Prepared a teaser and assisted the firm’s CFO in recap modeling, which included post-closing exit waterfall.
    • Supported Circle Peak Capital in executing a $5 million control investment in a luxury leather accessory retailer. Led target due diligence. Worked closely with the target's CEO and developed a detailed operating model with debt funding sensitivity tools.
    • Marketed a $30 million pre-IPO round for a Mongolian coking-coal firm to international buyers on behalf of Eurasia Capital, a Mongolia-based merchant bank. Commenced discussions with a global steel producer, which eventually expressed interest in acquiring a controlling stake in the company through a $100+ million transaction.
    • Supported Eurasia Capital in executing a $10 million private placement for a company with holdings in the mining equipment rental and real estate businesses. Led a team of Mongolian employees in drafting the PPM and coordinated with lawyers to finalize the book.
    • Served as interim CFO for Sellas Life Sciences and led the company's listing on NASDAQ and subsequent $10.7 million Series A financing.
    • Supported HHM Capital, a US-based globally-focused middle-market private equity firm, in developing a concept for raising a $500 million fund dedicated to Russia/CIS commercial aircraft aviation leasing. Wrote an investment memo, which included detailed industry and competitive positioning analysis. Presented the memo to the investment committee.
    • Led financial due diligence of a Russian aircraft lessor on behalf of HHM Capital. Built a financial projections model for a 130-aircraft lease portfolio. Developed lease pricing/valuation models. Acted as a communication and cultural link between the American private equity team and Russian executives.
    • Helped raise a structured vehicle for a mid-market commercial lender in Russia on behalf of HHM Capital. Led due diligence for a loan portfolio. Developed marketing materials for external fundraising.
    Focus areas: Business Development, Interim CFO, Market Research, Fundraising, Budgeting, Investor Relations, Valuation, Financial Modeling, Financial Planning & Analysis (FP&A), Mergers & Acquisitions (M&A)
  • Interim CFO

    2019 - 2019
    DIH International, Ltd.
    • Partnered with the CEO and COO to successfully deliver several milestones critical to preparation for a strategic transaction involving this $85 million in revenue/400 employee medical device manufacturer.
    • Coordinated the consolidated audit.
    • Built a sales force effectiveness-driven five-year projections model.
    • Prepared a comprehensive analysis of historical performance on consolidated basis; delivered working capital and cost reduction recommendations.
    Focus areas: CFO, Healthcare, Period-end Closings, Excel Modeling, Mergers & Acquisitions (M&A), Cross-border M&A, Budgeting, Initial Public Offerings, Financial Planning & Analysis (FP&A), SEC Financial Reporting, Audits
  • Chief Financial Officer

    2017 - 2018
    SELLAS Life Sciences (Nasdaq: SLS)
    • Completed the reverse merger of SELLAS into a Nasdaq-listed company; led post-M&A integration of two companies.
    • Secured SELLAS' public listing on NASDAQ and oversaw the company's shares commencing trading on the exchange.
    • Presided over $10.7 million Series A financing raised.
    • Led balance sheet restructuring and debt redemption negotiations.
    • Conducted ongoing SEC and internal reporting; oversaw SOX compliance; managed financial controls and procedures.
    • Sole-managed short-term cash budgeting and long-term projections modeling.
    • Attended and represented SELLAS at investor conferences and managed investor relations functions.
    • Managed accounts payable, liquidity, and treasury functions.
    Focus areas: Healthcare, Initial Public Offerings, Budgeting, Reverse Mergers, Audits, Fundraising, NASDAQ, Public Companies, Mergers & Acquisitions (M&A), CFO
  • Senior VP, Investment Analyst

    2011 - 2017
    CHR Capital
    • Led due diligence on four successfully closed private equity investments with $343 million in invested capital.
    • Sourced various acquisition and private equity investment opportunities.
    • Build financial projection models with valuation and investment return analyses.
    • Developed investment committee memoranda, presented an investment thesis, and secured approval to make investments.
    • Monitored investments as a board observer and assisted with business development efforts.
    • Assisted portfolio companies with capital raising and restructuring/reorganization advice.
    Focus areas: Financial Benchmarking, Fairness Opinion Reports, Fundraising, Investment Monitoring, Investor Relations, Venture Funding, Angel/Seed Funding, Growth Capital Raising, Capital Structure Analysis, Structuring, Financial Modeling, Mergers & Acquisitions (M&A), Deal Sourcing
  • Vice President

    2008 - 2009
    • Managed a team of three professionals in originating, executing, and managing principal debt investments in—and providing opportunistic advisory services to—Russian companies in the consumer, mineral resources, and technology sectors.
    • Led a distressed takeover of a seventeen-door grocery store chain in central Russia. Negotiated terms of the debt-for-equity swap. Developed a series of reorganization recommendations and worked with the store management on their implementation.
    • Secured a retainer relationship from a manufacturer of canned vegetable and fruit products. Advised the company on strategic alternatives, including optimization of its capital structure and growth via acquisitions along its vertical supply chain.
    • Originated a $10 million private placement for a delinquent consumer credit collection company. Negotiated the engagement letter. Led the team of bankers during the prep and marketing, which resulted in a term sheet.
    • Ran a sale process of a civil engineering construction company with revenues of $100+ million per annum. Placed sales calls to, and negotiated with, strategic and financial buyers.
    Focus areas: Fundraising, Mergers & Acquisitions (M&A)
  • Investment Analyst

    2005 - 2008
    Ener1 Group
    • Served as an investment analyst reporting directly to the CEO of this family office. Evaluated investment opportunities and helped manage a portfolio of industrial and technology firms. Led business development and capital raising activities across the entire portfolio.
    • Evaluated an equity investment in the carve-out of a Russian coal/ore railroad car fleet company. Prepared an investment committee presentation to a bulge-bracket-backed PE firm, which co-sponsored the deal.
    • Built a recapitalization model and evaluated restructuring scenarios for a $150 million market cap hybrid-electric vehicle battery manufacturer. Secured a leading mutual fund’s commitment as an anchor investor in the $32 million PIPE with subsequent uplisting on Nasdaq.
    • Analyzed an acquisition of a lead-acid battery manufacturer for the telecom industry. Performed valuation analysis. Delivered a recommended bid range to the board, which approved the transaction. Prepared and submitted a bid on behalf of the group.
    • Evaluated a venture investment into a video game developer/publisher and presented my recommendation to the board. The board voted to approve this $10 million investment.
    Focus areas: Venture Funding, Private Equity, Mergers & Acquisitions (M&A)
  • Financial Analyst

    2002 - 2005
    SG Cowen/Societe Generale
    • Supported senior bankers in origination, structuring, and execution of 46 private direct PIPEs/RDs placement and advisory engagements valued over $1.3 billion in the healthcare, technology, aerospace/defense, consumer, media, and communications industries.
    • Performed client due diligence, developed detailed financial models, and drafted private placement and investment memoranda and presentations.
    • Handled notable transactions: $63 million equity private placement for Acusphere across two deals; €30 million equity private placement for Elbion AG across two deals; $72 million equity private placement for AuthentiDate; $15 million equity private placement for Aurora Flight Sciences; fairness opinion on RWE's $445 million private sale of Consol Energy shares; $25 million equity private placement for Hollis-Eden Pharmaceuticals across two deals; and $32 million equity private placement for Solexa.
    Focus areas: Fundraising, Venture Funding

Other Experience

  • Thinking of Using a SPAC to Go Public? Here's What to Consider (Publication)
    “I know more people that have a SPAC than have COVID” is a common refrain among finance professionals these days. So what’s driving the spike? Is a SPAC IPO right for your company?
  • Fundraising is hard to get right, which is why companies of all sorts often turn to fundraising experts for help and advice regarding the fundraising process. There is a multitude of different professional figures that help companies raise capital, but for startups and growth companies, the two figures most often encountered are fundraising consultants and broker-dealers. Who is right for which endeavor?


  • Master of Business Administration (MBA) in General Management
    2009 - 2011
    Columbia Business School - New York, NY
  • Chartered Financial Analyst (CFA) in Finance
    2002 - 2005
    CFA Institute - Charlottesville, Virginia
  • Bachelor's Degree in Business Administration
    1998 - 2001
    Babson College - Wellesley, MA


  • S82
    FINRA Organization
  • S79
    JUNE 2013 - PRESENT
    FINRA Organization
  • S63
    JUNE 2013 - PRESENT
    FINRA Organization
  • Chartered Financial Analyst (CFA)
    CFA institute

To view more profiles

Join Toptal
Share it with others